What is NTHI's shares (diluted)?

NTHI (NTHI) reported shares (diluted) of 23.3M in Q1 2026.

How has NTHI's shares (diluted) changed year-over-year?

NTHI's shares (diluted) increased by 28.4% year-over-year, from 18.1M to 23.3M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

NTHI NTHI Shares (Diluted)

Shares (Diluted) at other companies

PfizerPFE

5.7B+0.4%

Nuvectis Pharma, Inc.NVCT

23.4M+17.4%

Oric Pharmaceuticals, Inc.ORIC

105.5M+48.5%

Nuvation BioNUVB

377.5M+11.5%

Crinetics PharmaceuticalsCRNX

104.1M+11.8%

Other financials

Income statement

See full

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

See full

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

See full

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

See full

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

See full

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

See full

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NTHI's shares (diluted)?: NTHI (NTHI) reported shares (diluted) of 23.3M in Q1 2026.
How has NTHI's shares (diluted) changed year-over-year?: NTHI's shares (diluted) increased by 28.4% year-over-year, from 18.1M to 23.3M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.